CGBIO_EN
CGBIO
Menu
  • About CGBio
    • Introduce
    • Message CEO
    • Business Area
    • Global Business
    • History
    • Contact us
      • Network
      • Global Network
  • R & D
    • R&D Introduction
    • R&D Areas
    • Accreditation and Patent
    • Research Info
    • Investigator Initiated Studies
  • Product
    • All Product
    • Bone/Spinal
    • Surgical
    • Wound
    • Aesthetics
    • Intervention
    • Dental
    • 3D Printing
  • News
    • Press Release
    • 2025 Exhibit
  • Anomaly
    • Incident Report Agree
    • Incident Report Reading
  • ENG
    • KOR
Open
Close
Sitemap
시지바이오 사이트맵 닫기
About CGBio
Introduce
Message CEO
Business Area
Global Business
History
Contact Us
  • Network
  • Global Network
R & D
R&D Introduction
R&D Areas
Accreditation and patent
Research Info
Product
All
Bone/Spinal
  • NOVOSIS
  • BONGENER
  • CGDBM ALLOMIX
  • EXCELOS INJECT
  • BONGROS
  • CGDERM ONE-STEP RESHOULDER
  • CG SYNOVIA
  • LUMFIX
  • LUMFIX CAGE
  • NOVOMAX, NOVOMAX FUSION
  • CERVICAL SPACER C+
  • TRISECURE
  • EXCENDER
Surgical
  • CGDERM ONE-STEP
  • MEDICLORE
  • CG REALLO – PUTTY
  • CG REALLO INJECT
Wound
  • CURAVAC
  • CuraVAC SILVER
  • CURASYS
  • EASYEF
  • EASYEF / SAESAL OINTMENT
  • EASYFOAM
  • EASYFOAM SILICONE BORDER
  • EASYDERM PLUS THIN
AESTHETICS
  • AILEENE, GISELLELIGNE
  • FACETEM S
  • CELLUNIT
Intervention
  • D+STORM DES
  • D+STORM BMS
  • TIGER
  • TRESO PTCA
  • TRESO NC PTCA
  • ALPHA STENT SYSTEM
  • TRESO PTA BALLOON
  • VOLANTE MICROCATHETER
  • CG GEL
Dental
  • NOVOSIS DENT
  • BONGENER
  • EXCELOS INJECT
  • BONGROS
3D Printing
  • EASY MADE CF
  • LUCA
News
Press Release
D+Wound Solution
2025 Exhibit
Anomaly
Incident Report
View your Incident Report
home

News

Press Release

  • Press Release
  • 2025 Exhibit
Press Release

Press Release

Posterolateral lumbar fusion results similar between E.BMP-2, autogenous bone graft

Posterolateral lumbar fusion results similar between E.BMP-2, autogenous bone graft

The fusion rate of Escherichia coli-derived recombinant human bone morphogenetic protein-2 following posterolateral lumbar fusion was similar to autogenous iliac bone graft, according…

  • 2018-02-26
  • cgbio
South Korea’s first rhBMP-2 bone graft receives government recognition

South Korea’s first rhBMP-2 bone graft receives government recognition

South Korean biomaterials company CG Bio has received a ‘World Class Product of Korea’ award from the Ministry of Trade, Industry and…

  • 2017-12-07
  • cgbio
2016 D+Bone Solution

2016 D+Bone Solution

Program Download

  • 2016-12-13
  • cgbio
2016 D+Wound Solution

2016 D+Wound Solution

Program Download

  • 2016-07-21
  • cgbio
BioAlpha Inc. ‘Novomax’ was awarded the Minister prize of Ministry of Trade, Industry and Energy(MOTIE)

BioAlpha Inc. ‘Novomax’ was awarded the Minister prize of Ministry of Trade, Industry and Energy(MOTIE)

BioAlpha Inc. ‘Novomax’ was awarded the Minister prize of Ministry of Trade, Industry and Energy(MOTIE) The world’s first new material with bioactive…

  • 2016-02-24
  • cgbio
2015 EWMA

2015 EWMA

  • 2015-05-20
  • cgbio
2014 EWMA

2014 EWMA

  • 2015-03-12
  • cgbio
CG BIO at SAWC 2014

CG BIO at SAWC 2014

  • 2015-03-04
  • cgbio
2014 AAOS Conference

2014 AAOS Conference

  • 2015-03-02
  • cgbio
Page 9 of 9«123456789

Head Office : F3, 211, Itaewon-ro, Yongsan-gu, Seoul, Korea
Research Institute : 244, Galmachi-ro,Jungwon-gu,Seongnam-si, Gyeonggi-do,Korea
Head Office TEL. +82-2-550-8300

Copyright All Right Reserverd By CGbio

링크드인 인스타그램 페이스북

  • Family site
    • DNC

to be updated.

OK close
popimg_200407 연구요약문 CGBIO R&D 파일 다운로드 close